September 28th, 2026 | 10am-2pm ET | CIC Cambridge

What We'll Explore

• Designing Better Candidates: How discovery and engineering strategies can build stronger therapeutic antibodies from the start
• Generating the Right Data: Looking beyond traditional readouts to understand function, mechanism, and developability
• Making Better Development Decisions: Bringing the data together to confidently differentiate candidates and determine which molecules move forward

From Design To Decision

Join a small group of antibody developers and industry leaders for a discussion-focused symposium exploring how data across discovery, engineering, characterization, and development can inform one of the most important decisions in drug development: which molecule moves forward? 

About the Co-Hosts

SeromYx Systems

SeromYx Systems is a biotechnology company specializing in comprehensive antibody characterization to support vaccine and antibody therapeutic development.

SeromYx combines biophysical characterization with antigen-specific functional assays using primary human effector cells to provide deeper insight into antibody activity and immune function.

Across discovery, preclinical, and clinical programs, SeromYx helps developers differentiate candidates, understand mechanisms of action, and generate biologically relevant data to inform development decisions.

Our clients trust us for our scientific expertise and commitment to helping move antibody programs forward.

AVS Bio

AVS Bio is a global company supporting the development of biologics for animal and human health with products and services at its operational sites in North America and Europe.

AVS Bio offers design-driven antibody discovery and development services, tailored to target insights and lead antibody requirements. Since 2018, AVS Bio has supported more than 100 life sciences companies launch successful lead antibody programs, including the development of 10 antibodies that entered clinical trials.

AVS Bio completed over 3,250 standalone protein production and purification programs over the past decades.

Our clients trust us for our expertise, efficiency, and commitment to turning complex challenges into successful outcomes.

RoukenBio

RoukenBio - Immunology CRO redefined is providing discovery to IND-enabling immunology and bioassay research services to a global customer base in the therapeutic areas of inflammation, auto-immunity, immuno-oncology, oncology and beyond. Our vision is to become the most trusted research partner for biotherapeutic innovators.

Backed by our brilliant minds, we have turned the traditional CRO model on its head by fostering a collaborative and personalised approach.

Our mission is simple: Solve problems. Deliver quality data. Propel your drug discovery breakthroughs.

In The Heart of Boston's Biotech Community

The symposium will be held at CIC Cambridge, bringing the conversation into one of the country’s leading hubs for biotech and life sciences.

Conveniently located for both local attendees and those joining us around Discovery on Target, CIC offers an ideal setting for a small, discussion-focused gathering of antibody developers and industry leaders.

CIC Cambridge
1 Broadway
Cambridge, MA 02142